Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8+ T cell responses
| Autor: | Peter R. Hoffmann, Stefan Moisyadi, Woo Hyun Park, Aaron H. Rose, FuKun W. Hoffmann, Bo Ra You, Johann Urschitz, Pietro Bertino |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Transgene
T cell Genetic Vectors CD8-Positive T-Lymphocytes Biology Transfection Article DNA vaccination Mice Plasmid Antigen Genes Reporter Vaccines DNA Splenocyte medicine Animals Humans Cytotoxic T cell Transgenes Immunity Cellular Mice Inbred BALB C General Veterinary General Immunology and Microbiology Public Health Environmental and Occupational Health Molecular biology HEK293 Cells Infectious Diseases medicine.anatomical_structure Molecular Medicine Female CD8 Plasmids |
| Zdroj: | Vaccine. 32:1670-1677 |
| ISSN: | 0264-410X |
| Popis: | DNA vaccination with plasmid has conventionally involved vectors designed for transient expression of antigens in injected tissues. Next generation plasmids are being developed for site-directed integration of transgenes into safe sites in host genomes and may provide an innovative approach for stable and sustained expression of antigens for vaccination. The goal of this study was to evaluate in vivo antigen expression and the generation of cell mediated immunity in mice injected with a non-integrating plasmid compared to a plasmid with integrating potential. Hyperactive piggyBac transposase-based integrating vectors (pmhyGENIE-3) contained a transgene encoding either eGFP (pmhyGENIE-3-eGFP) or luciferase (pmhyGENIE-3-GL3), and were compared to transposase-deficient plasmids with the same transgene and DNA backbone. Both non-integrating and integrating plasmids were equivalent at day 1 for protein expression at the site of injection. While protein expression from the non-integrating plasmid was lost by day 14, the pmhyGENIE-3 was found to exhibit sustained protein expression up to 28 days post-injection. Vaccination with pmhyGENIE-3-eGFP resulted in a robust CD8(+) T cell response that was three-fold higher than that of non-integrating plasmid vaccinations. Additionally we observed in splenocyte restimulation experiments that only the vaccination with pmhyGENIE-3-eGFP was characterized by IFNγ producing CD8(+) T cells. Overall, these findings suggest that plasmids designed to direct integration of transgenes into the host genome are a promising approach for designing DNA vaccines. Robust cell mediated CD8(+) T cell responses generated using integrating plasmids may provide effective, sustained protection against intracellular pathogens or tumor antigens. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect